News & Articles

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

R&D expert Dr. Francisco Ylera shares the secret to fast and flexible formatting of antibodies to accelerate your research

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

Discover on demand an antibody discovery campaign targeting a cell surface receptor implicated in cancer

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations

Don't miss this webinar to find out how researchers at LifeArc are using ALK-specific antibodies as a mechanism of directly targeting ALK-expressing neuroblastoma cells

Our expert webinar series aims to help you get the most from your drug discovery research

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Join us on Tuesday, June 9, to explore the qualitative and quantitative characterization of mAb and protein stability, both in vitro and in vivo, by CE-MS and LC-MS

Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services

Download this white paper from Sartorius to discover how enhanced data analytics and translational models can provide new biological insights

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.